{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:32:53Z","timestamp":1787315573109,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40256-026-00806-8","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:06:14Z","timestamp":1782234374000},"page":"523-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["De-risking Atrial Fibrillation: Refining Anticoagulation Decision-Making"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6631-2554","authenticated-orcid":false,"given":"Navid","family":"Radfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhir","family":"Gala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Allencherril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"9","key":"806_CR1","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jacc.2023.12.033","volume":"83","author":"JD Newman","year":"2024","unstructured":"Newman JD, O\u2019Meara E, Bohm M, et al. Implications of atrial fibrillation for guideline-directed therapy in patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2024;83(9):932\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"806_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014549","volume":"98","author":"S Yan","year":"2019","unstructured":"Yan S, Li Q, Xia Z, et al. Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score. Medicine (Baltimore). 2019;98(8):e14549.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"806_CR3","doi-asserted-by":"publisher","first-page":"e211693","DOI":"10.1001\/jamahealthforum.2021.1693","volume":"2","author":"A Troy","year":"2021","unstructured":"Troy A, Anderson TS. National trends in use of and spending on oral anticoagulants among US Medicare Beneficiaries From 2011 to 2019. JAMA Health Forum. 2021;2(7):e211693\u2013e211693.","journal-title":"JAMA Health Forum."},{"issue":"3","key":"806_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.amepre.2023.10.014","volume":"66","author":"JS Lee","year":"2024","unstructured":"Lee JS, Han S, Therrien NL, Park C, Luo F, Essien UR. Trends in drug spending of oral anticoagulants for atrial fibrillation, 2014\u20132021. Am J Prev Med. 2024;66(3):463\u201372.","journal-title":"Am J Prev Med"},{"issue":"1","key":"806_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1\u2013156.","journal-title":"Circulation"},{"issue":"4","key":"806_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.tcm.2024.12.003","volume":"35","author":"S Ortega-Martorell","year":"2025","unstructured":"Ortega-Martorell S, Olier I, Ohlsson M, Lip GYH. Advancing personalised care in atrial fibrillation and stroke: the potential impact of AI from prevention to rehabilitation. Trends Cardiovasc Med. 2025;35(4):205\u201311.","journal-title":"Trends Cardiovasc Med"},{"issue":"22","key":"806_CR7","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting StrokeResults From the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864\u201370.","journal-title":"JAMA"},{"issue":"2","key":"806_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ccep.2012.02.001","volume":"4","author":"A Brann","year":"2012","unstructured":"Brann A, Day JD, Bunch TJ. The role of anticoagulation in a patient with atrial fibrillation and a CHADS2 Score of 1. Card Electrophysiol Clin. 2012;4(2):107\u201317.","journal-title":"Card Electrophysiol Clin."},{"issue":"36","key":"806_CR9","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1093\/eurheartj\/ehae540","volume":"45","author":"GYH Lip","year":"2024","unstructured":"Lip GYH, Teppo K, Nielsen PB. CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications. Eur Heart J. 2024;45(36):3718\u201320.","journal-title":"Eur Heart J"},{"issue":"12","key":"806_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","volume":"107","author":"AJ Wagstaff","year":"2014","unstructured":"Wagstaff AJ, Overvad TF, Lip GY, Lane DA. Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. QJM. 2014;107(12):955\u201367.","journal-title":"QJM"},{"key":"806_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h7013","volume":"532","author":"CA Emdin","year":"2016","unstructured":"Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ. 2016;532:h7013.","journal-title":"BMJ"},{"issue":"8","key":"806_CR12","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","volume":"137","author":"PB Nielsen","year":"2018","unstructured":"Nielsen PB, Skj\u00f8th F, Overvad TF, Larsen TB, Lip GYH. Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA(2)DS(2)-VA Score Rather Than CHA(2)DS(2)-VASc? Circulation. 2018;137(8):832\u201340.","journal-title":"Circulation"},{"issue":"3","key":"806_CR13","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1161\/STROKEAHA.116.015900","volume":"48","author":"C Lang","year":"2017","unstructured":"Lang C, Seyfang L, Ferrari J, et al. Do women with atrial fibrillation experience more severe strokes? Results from the Austrian Stroke Unit Registry. Stroke. 2017;48(3):778\u201380.","journal-title":"Stroke"},{"key":"806_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100967","volume":"43","author":"K Teppo","year":"2024","unstructured":"Teppo K, Lip GYH, Airaksinen KEJ, et al. Comparing CHA(2)DS(2)-VA and CHA(2)DS(2)-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort. Lancet Reg Health Eur. 2024;43:100967.","journal-title":"Lancet Reg Health Eur."},{"key":"806_CR15","doi-asserted-by":"crossref","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J 2024;45(36):3314\u20133414.","DOI":"10.1093\/eurheartj\/ehae176"},{"issue":"2","key":"806_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/europace\/euaa358","volume":"23","author":"J Zhang","year":"2021","unstructured":"Zhang J, Lenarczyk R, Marin F, et al. The interpretation of CHA2DS2-VASc score components in clinical practice: a joint survey by the European Heart Rhythm Association (EHRA) Scientific Initiatives Committee, the EHRA Young Electrophysiologists, the Association of Cardiovascular Nursing and Allied Professionals, and the European Society of Cardiology Council on Stroke. Europace. 2021;23(2):314\u201322.","journal-title":"Europace"},{"issue":"6","key":"806_CR17","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13\u2013115.","journal-title":"Hypertension"},{"issue":"3","key":"806_CR18","first-page":"229","volume":"15","author":"J Wang","year":"2018","unstructured":"Wang J, Zhang DP, Liu HB, Zhong JC, Yang XC. Should atrial fibrillation patients with hypertension as an additional risk factor of the CHA2DS2-VASc score receive oral anticoagulation? J Geriatr Cardiol. 2018;15(3):229\u201334.","journal-title":"J Geriatr Cardiol"},{"issue":"3","key":"806_CR19","first-page":"258","volume":"10","author":"JY Chen","year":"2013","unstructured":"Chen JY, Zhang AD, Lu HY, Guo J, Wang FF, Li ZC. CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis. J Geriatr Cardiol. 2013;10(3):258\u201366.","journal-title":"J Geriatr Cardiol"},{"issue":"2","key":"806_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"key":"806_CR21","doi-asserted-by":"crossref","unstructured":"Mitsios JP, Ekinci EI, Mitsios GP, Churilov L, Thijs V. Relationship between glycated hemoglobin and stroke risk: a systematic review and meta\u2010analysis. J Am Heart Assoc 7(11):7858.","DOI":"10.1161\/JAHA.117.007858"},{"issue":"4","key":"806_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","volume":"58","author":"MC Fang","year":"2011","unstructured":"Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011;58(4):395\u2013401.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"806_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","volume":"151","author":"BF Gage","year":"2006","unstructured":"Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3):713\u20139.","journal-title":"Am Heart J"},{"issue":"5","key":"806_CR24","first-page":"429","volume":"2","author":"AR Patrick","year":"2009","unstructured":"Patrick AR, Avorn J, Choudhry NK. Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation. Circulation. 2009;2(5):429\u201336.","journal-title":"Circulation"},{"issue":"5","key":"806_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014574","volume":"9","author":"T Maeda","year":"2020","unstructured":"Maeda T, Nishi T, Funakoshi S, et al. Risks of bleeding and stroke based on CHA2DS2-VASc scores in Japanese patients with atrial fibrillation: a large-scale observational study using real-world data. J Am Heart Assoc. 2020;9(5):e014574.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"806_CR26","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1253\/circj.CJ-14-0584","volume":"78","author":"GY Lip","year":"2014","unstructured":"Lip GY, Lane DA. Modern management of atrial fibrillation requires initial identification of \u201clow-risk\u201d patients using the CHA2DS2-VASc score, and not focusing on \u201chigh-risk\u201d prediction. Circ J. 2014;78(8):1843\u20135.","journal-title":"Circ J"},{"issue":"5","key":"806_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093\u2013100.","journal-title":"Chest"},{"issue":"9","key":"806_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jacc.2012.06.019","volume":"60","author":"S Apostolakis","year":"2012","unstructured":"Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol. 2012;60(9):861\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"806_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1378\/chest.12-0608","volume":"143","author":"V Rold\u00e1n","year":"2013","unstructured":"Rold\u00e1n V, Mar\u00edn F, Fern\u00e1ndez H, et al. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a \u201creal-world\u201d population with atrial fibrillation receiving anticoagulant therapy. Chest. 2013;143(1):179\u201384.","journal-title":"Chest"},{"issue":"3","key":"806_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jacc.2012.10.010","volume":"61","author":"S Apostolakis","year":"2013","unstructured":"Apostolakis S, Lane Deirdre A, Guo Y, Buller H, Lip Gregory YH. Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED bleeding risk\u2013prediction scores in nonwarfarin anticoagulated atrial fibrillation patients. JACC. 2013;61(3):386\u20137.","journal-title":"JACC"},{"issue":"9","key":"806_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/clc.22435","volume":"38","author":"W Zhu","year":"2015","unstructured":"Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis. Clin Cardiol. 2015;38(9):555\u201361.","journal-title":"Clin Cardiol"},{"issue":"3","key":"806_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10840-014-9930-y","volume":"40","author":"D Caldeira","year":"2014","unstructured":"Caldeira D, Costa J, Fernandes RM, Pinto FJ, Ferreira JJ. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2014;40(3):277\u201384.","journal-title":"J Interv Card Electrophysiol"},{"issue":"1","key":"806_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2217\/fca-2020-0014","volume":"17","author":"JP Bassand","year":"2021","unstructured":"Bassand JP, Apenteng PN, Atar D, et al. GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke. Future Cardiol. 2021;17(1):19\u201338.","journal-title":"Future Cardiol"},{"issue":"2","key":"806_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/ehjqcco\/qcab028","volume":"8","author":"KAA Fox","year":"2022","unstructured":"Fox KAA, Virdone S, Pieper KS, et al. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2022;8(2):214\u201327.","journal-title":"Eur Heart J Qual Care Clin Outcomes."},{"key":"806_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.carrev.2023.10.007","volume":"60","author":"A Ali","year":"2024","unstructured":"Ali A, Siddiqui AA, Ali M, Shahid I. Meta-analysis on performance of ABC and GARFIELD-AF compared to CHA2DS2-VASc and HAS-BLED in anticoagulated atrial fibrillation patients. Cardiovasc Revasc Med. 2024;60:74\u201381.","journal-title":"Cardiovasc Revasc Med"},{"issue":"08","key":"806_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1055\/a-1333-4448","volume":"121","author":"M Proietti","year":"2021","unstructured":"Proietti M, Rivera-Caravaca JM, Esteve-Pastor MA, Mar\u00edn F, Lip GYH. Stroke and thromboembolism in warfarin-treated patients with atrial fibrillation: comparing the CHA2DS2-VASc and GARFIELD-AF risk scores. Thromb Haemost. 2021;121(08):1107\u201314.","journal-title":"Thromb Haemost"},{"issue":"20","key":"806_CR37","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","volume":"381","author":"MV Perez","year":"2019","unstructured":"Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381(20):1909\u201317.","journal-title":"N Engl J Med"},{"issue":"3","key":"806_CR38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.12998\/wjcc.v10.i3.939","volume":"10","author":"SY Yang","year":"2022","unstructured":"Yang SY, Huang M, Wang AL, et al. Atrial fibrillation burden and the risk of stroke: a systematic review and dose-response meta-analysis. World J Clin Cases. 2022;10(3):939\u201353.","journal-title":"World J Clin Cases."},{"issue":"2","key":"806_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa2310234","volume":"390","author":"JS Healey","year":"2024","unstructured":"Healey JS, Lopes RD, Granger CB, et al. Apixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med. 2024;390(2):107\u201317.","journal-title":"N Engl J Med"},{"issue":"5","key":"806_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","volume":"2","author":"TV Glotzer","year":"2009","unstructured":"Glotzer TV, Daoud EG, Wyse DG, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2(5):474\u201380.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"17","key":"806_CR41","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","volume":"38","author":"IC Van Gelder","year":"2017","unstructured":"Van Gelder IC, Healey JS, Crijns HJGM, et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017;38(17):1339\u201344.","journal-title":"Eur Heart J"},{"key":"806_CR42","doi-asserted-by":"crossref","unstructured":"Connolly Stuart J, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med 364(9):806-817.","DOI":"10.1056\/NEJMoa1007432"},{"issue":"21","key":"806_CR43","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/j.jacc.2024.08.019","volume":"84","author":"RD Lopes","year":"2024","unstructured":"Lopes RD, Atlas SJ, Go AS, et al. Effect of screening for undiagnosed atrial fibrillation on stroke prevention. J Am Coll Cardiol. 2024;84(21):2073\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"10310","key":"806_CR44","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","volume":"398","author":"JH Svendsen","year":"2021","unstructured":"Svendsen JH, Diederichsen SZ, H\u00f8jberg S, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021;398(10310):1507\u201316.","journal-title":"Lancet"},{"issue":"17","key":"806_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.036429","volume":"13","author":"HC Diener","year":"2024","unstructured":"Diener HC, Becher N, Sehner S, et al. Anticoagulation in patients with Device\u2010detected atrial fibrillation with and without a prior stroke or transient ischemic attack: the NOAH\u2010AFNET 6 Trial. J Am Heart Assoc. 2024;13(17):e036429.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"806_CR46","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jama.2025.14679","volume":"334","author":"D Kim","year":"2025","unstructured":"Kim D, Shim J, Choi EK, et al. Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial. JAMA. 2025;334(14):1246\u201354.","journal-title":"JAMA"},{"key":"806_CR47","doi-asserted-by":"publisher","first-page":"S304","DOI":"10.1111\/jth.12974","volume":"13","author":"A Bessissow","year":"2015","unstructured":"Bessissow A, Khan J, Devereaux PJ, Alvarez-Garcia J, Alonso-Coello P. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost. 2015;13:S304\u201312.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"806_CR48","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","volume":"120","author":"L Staerk","year":"2017","unstructured":"Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017;120(9):1501\u201317.","journal-title":"Circ Res"},{"issue":"6","key":"806_CR49","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jacbts.2022.12.004","volume":"8","author":"PE Lazzerini","year":"2023","unstructured":"Lazzerini PE, Abbate A, Boutjdir M, Capecchi PL. Fir(e)ing the rhythm: inflammatory cytokines and cardiac arrhythmias. JACC Basic Transl Sci. 2023;8(6):728\u201350.","journal-title":"JACC Basic Transl Sci."},{"issue":"9","key":"806_CR50","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","volume":"114","author":"PS Chen","year":"2014","unstructured":"Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114(9):1500\u201315.","journal-title":"Circ Res"},{"key":"806_CR51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejim.2021.10.022","volume":"98","author":"I Induruwa","year":"2022","unstructured":"Induruwa I, Hennebry E, Hennebry J, Thakur M, Warburton EA, Khadjooi K. Sepsis-driven atrial fibrillation and ischaemic stroke Is there enough evidence to recommend anticoagulation? Eur J Intern Med. 2022;98:32\u20136.","journal-title":"Eur J Intern Med"},{"issue":"8","key":"806_CR52","volume":"12","author":"K Arunachalam","year":"2020","unstructured":"Arunachalam K, Kalyan Sundaram A, Jha K, Thakur L, Pond K. Evaluation of anticoagulation practice with new-onset atrial fibrillation in patients with sepsis and septic shock in medical intensive care unit: a retrospective observational cohort study. Cureus. 2020;12(8):e10026.","journal-title":"Cureus."},{"issue":"8","key":"806_CR53","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1161\/STROKEAHA.119.025384","volume":"50","author":"K Jordan","year":"2019","unstructured":"Jordan K, Yaghi S, Poppas A, et al. Left atrial volume index is associated with cardioembolic stroke and atrial fibrillation detection after embolic stroke of undetermined source. Stroke. 2019;50(8):1997\u20132001.","journal-title":"Stroke"},{"issue":"6","key":"806_CR54","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/STROKEAHA.115.008711","volume":"46","author":"S Yaghi","year":"2015","unstructured":"Yaghi S, Moon YP, Mora-McLaughlin C, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke. 2015;46(6):1488\u201393.","journal-title":"Stroke"},{"issue":"10","key":"806_CR55","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1161\/01.STR.30.10.2019","volume":"30","author":"MR Di Tullio","year":"1999","unstructured":"Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30(10):2019\u201324.","journal-title":"Stroke"},{"issue":"9","key":"806_CR56","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0002-9149(01)01460-6","volume":"87","author":"JM Gardin","year":"2001","unstructured":"Gardin JM, McClelland R, Kitzman D, et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol. 2001;87(9):1051\u20137.","journal-title":"Am J Cardiol"},{"issue":"3","key":"806_CR57","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacep.2019.12.013","volume":"6","author":"JK Sajeev","year":"2020","unstructured":"Sajeev JK, Kalman JM, Dewey H, Cooke JC, Teh AW. The atrium and embolic stroke: myopathy not atrial fibrillation as the requisite determinant? JACC Clin Electrophysiol. 2020;6(3):251\u201361.","journal-title":"JACC Clin Electrophysiol."},{"issue":"3","key":"806_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imag. 2015;16(3):233\u201371.","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"806_CR59","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.wneu.2021.12.003","volume":"159","author":"H Sato","year":"2022","unstructured":"Sato H, Saito M, Mitsui N, et al. Left atrial volume index as a predictor for large-vessel occlusion in cardiogenic cerebral infarction: a single-center cohort study. World Neurosurg. 2022;159:e79\u201383.","journal-title":"World Neurosurg."},{"key":"806_CR60","doi-asserted-by":"publisher","first-page":"1265037","DOI":"10.3389\/fneur.2023.1265037","volume":"14","author":"M Homssi","year":"2023","unstructured":"Homssi M, Balaji V, Zhang C, Shin J, Gupta A, Kamel H. Association between left atrial volume index and infarct volume in patients with ischemic stroke. Front Neurol. 2023;14:1265037.","journal-title":"Front Neurol"},{"issue":"12","key":"806_CR61","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.029259","volume":"12","author":"L Segan","year":"2023","unstructured":"Segan L, Nanayakkara S, Spear E, et al. Identifying patients at high risk of left atrial appendage thrombus before cardioversion: the CLOTS-AF Score. J Am Heart Assoc. 2023;12(12):e029259.","journal-title":"J Am Heart Assoc"},{"key":"806_CR62","doi-asserted-by":"crossref","unstructured":"Collado FMS, Lama von Buchwald CM, Anderson CK, et al. Left atrial appendage occlusion for stroke prevention in nonvalvular atrial fibrillation. J American Heart Association. 2021;10(21):e022274.","DOI":"10.1161\/JAHA.121.022274"},{"issue":"9","key":"806_CR63","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1540-8167.2010.01814.x","volume":"21","author":"Y Wang","year":"2010","unstructured":"Wang Y, Di Biase L, Horton RP, Nguyen T, Morhanty P, Natale A. Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. J Cardiovasc Electrophysiol. 2010;21(9):973\u201382.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"6","key":"806_CR64","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jacc.2012.04.032","volume":"60","author":"L Di Biase","year":"2012","unstructured":"Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation?: results from a multicenter study. J Am Coll Cardiol. 2012;60(6):531\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"806_CR65","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.hrthm.2016.03.042","volume":"13","author":"F Lupercio","year":"2016","unstructured":"Lupercio F, Carlos Ruiz J, Briceno DF, et al. Left atrial appendage morphology assessment for risk stratification of embolic stroke in patients with atrial fibrillation: a meta-analysis. Heart Rhythm. 2016;13(7):1402\u20139.","journal-title":"Heart Rhythm"},{"issue":"1","key":"806_CR66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12872-018-0889-y","volume":"18","author":"F Wang","year":"2018","unstructured":"Wang F, Zhu M, Wang X, et al. Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord. 2018;18(1):153.","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"806_CR67","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/europace\/euu347","volume":"17","author":"M Petersen","year":"2015","unstructured":"Petersen M, Roehrich A, Balzer J, et al. Left atrial appendage morphology is closely associated with specific echocardiographic flow pattern in patients with atrial fibrillation. Europace. 2015;17(4):539\u201345.","journal-title":"Europace"},{"issue":"4","key":"806_CR68","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamacardio.2022.5449","volume":"8","author":"C Mannina","year":"2023","unstructured":"Mannina C, Ito K, Jin Z, et al. Association of left atrial strain with ischemic stroke risk in older adults. JAMA Cardiol. 2023;8(4):317\u201325.","journal-title":"JAMA Cardiol."},{"issue":"5","key":"806_CR69","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.echo.2011.01.016","volume":"24","author":"JY Shih","year":"2011","unstructured":"Shih JY, Tsai WC, Huang YY, et al. Association of decreased left atrial strain and strain rate with stroke in chronic atrial fibrillation. J Am Soc Echocardiogr. 2011;24(5):513\u20139.","journal-title":"J Am Soc Echocardiogr"},{"key":"806_CR70","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.amjcard.2023.10.001","volume":"210","author":"A Vera","year":"2024","unstructured":"Vera A, Cecconi A, Xim\u00e9nez-Carrillo \u00c1, et al. Left atrial strain predicts stroke recurrence and death in patients with cryptogenic stroke. Am J Cardiol. 2024;210:51\u20137.","journal-title":"Am J Cardiol"},{"issue":"3","key":"806_CR71","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/ehjci\/jeaa287","volume":"23","author":"AS Alhakak","year":"2022","unstructured":"Alhakak AS, Biering-S\u00f8rensen SR, M\u00f8gelvang R, et al. Usefulness of left atrial strain for predicting incident atrial fibrillation and ischaemic stroke in the general population. Eur Heart J Cardiovasc Imaging. 2022;23(3):363\u201371.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"10","key":"806_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077653","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, Ding W, Wang H, et al. Relationship of CHA2DS2-VASc and CHADS2 score to left atrial remodeling detected by velocity vector imaging in patients with atrial fibrillation. PLoS ONE. 2013;8(10):e77653.","journal-title":"PLoS ONE"},{"issue":"10","key":"806_CR73","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.echo.2022.05.018","volume":"35","author":"A Bhat","year":"2022","unstructured":"Bhat A, Chen HHL, Khanna S, et al. Diagnostic and prognostic value of left atrial function in identification of cardioembolism and prediction of outcomes in patients with cryptogenic stroke. J Am Soc Echocardiogr. 2022;35(10):1064\u201376.","journal-title":"J Am Soc Echocardiogr"},{"issue":"19","key":"806_CR74","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.jacc.2007.02.037","volume":"49","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol. 2007;49(19):1943\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"806_CR75","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","volume":"108","author":"SK James","year":"2003","unstructured":"James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation. 2003;108(3):275\u201381.","journal-title":"Circulation"},{"issue":"7","key":"806_CR76","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1056\/NEJMoa042330","volume":"352","author":"C Kragelund","year":"2005","unstructured":"Kragelund C, Gr\u00f8nning B, K\u00f8ber L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005;352(7):666\u201375.","journal-title":"N Engl J Med"},{"issue":"2","key":"806_CR77","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/01.CIR.96.2.509","volume":"96","author":"T Tsutamoto","year":"1997","unstructured":"Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96(2):509\u201316.","journal-title":"Circulation"},{"issue":"7","key":"806_CR78","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMoa031994","volume":"350","author":"TJ Wang","year":"2004","unstructured":"Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350(7):655\u201363.","journal-title":"N Engl J Med"},{"issue":"18","key":"806_CR79","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","volume":"120","author":"KK Patton","year":"2009","unstructured":"Patton KK, Ellinor PT, Heckbert SR, et al. N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study. Circulation. 2009;120(18):1768\u201374.","journal-title":"Circulation"},{"issue":"13","key":"806_CR80","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","volume":"125","author":"Z Hijazi","year":"2012","unstructured":"Hijazi Z, Oldgren J, Andersson U, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012;125(13):1605\u201316.","journal-title":"Circulation"},{"issue":"22","key":"806_CR81","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.jacc.2012.11.082","volume":"61","author":"Z Hijazi","year":"2013","unstructured":"Hijazi Z, Wallentin L, Siegbahn A, et al. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol. 2013;61(22):2274\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"806_CR82","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","volume":"37","author":"Z Hijazi","year":"2016","unstructured":"Hijazi Z, Lindb\u00e4ck J, Alexander JH, et al. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J. 2016;37(20):1582\u201390.","journal-title":"Eur Heart J"},{"issue":"20","key":"806_CR83","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1097\/CM9.0000000000002833","volume":"136","author":"Y Wang","year":"2023","unstructured":"Wang Y, Jiang C, He L, et al. ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry. Chin Med J (Engl). 2023;136(20):2451\u20138.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"806_CR84","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3349\/ymj.2022.0157","volume":"63","author":"M Jung","year":"2022","unstructured":"Jung M, Byeon K, Kang KW, et al. Validation of biomarker-based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA(2)DS(2)-VASc Score 0\u20131: a Korean Multi-Center Cohort. Yonsei Med J. 2022;63(10):892\u2013901.","journal-title":"Yonsei Med J"},{"issue":"1","key":"806_CR85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/07853890.2017.1378429","volume":"50","author":"V Rold\u00e1n","year":"2018","unstructured":"Rold\u00e1n V, Rivera-Caravaca JM, Shantsila A, et al. Enhancing the \u201creal world\u201d prediction of cardiovascular events and major bleeding with the CHA(2)DS(2)-VASc and HAS-BLED scores using multiple biomarkers. Ann Med. 2018;50(1):26\u201334.","journal-title":"Ann Med"},{"issue":"23","key":"806_CR86","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1136\/hrt.2009.191460","volume":"96","author":"S Masson","year":"2010","unstructured":"Masson S, Aleksova A, Favero C, et al. Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial. Heart. 2010;96(23):1909\u201314.","journal-title":"Heart"},{"issue":"3","key":"806_CR87","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ijcard.2005.05.021","volume":"108","author":"E Watanabe","year":"2006","unstructured":"Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol. 2006;108(3):346\u201353.","journal-title":"Int J Cardiol"},{"issue":"10","key":"806_CR88","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1540-8167.2011.02069.x","volume":"22","author":"M Schmidt","year":"2011","unstructured":"Schmidt M, Daccarett M, Rittger H, et al. Renal dysfunction and atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol. 2011;22(10):1092\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"806_CR89","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","volume":"119","author":"AS Go","year":"2009","unstructured":"Go AS, Fang MC, Udaltsova N, et al. Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation. 2009;119(10):1363\u20139.","journal-title":"Circulation"},{"issue":"2","key":"806_CR90","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.112.107128","volume":"127","author":"JP Piccini","year":"2013","unstructured":"Piccini JP, Stevens SR, Chang Y, et al. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation. 2013;127(2):224\u201332.","journal-title":"Circulation"},{"issue":"1","key":"806_CR91","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12947-019-0158-y","volume":"17","author":"Y Wang","year":"2019","unstructured":"Wang Y, Li Z, Fei H, et al. Left atrial strain reproducibility using vendor-dependent and vendor-independent software. Cardiovasc Ultrasound. 2019;17(1):9.","journal-title":"Cardiovasc Ultrasound"},{"key":"806_CR92","doi-asserted-by":"crossref","unstructured":"Korsholm K, Berti S, Iriart X, et al. Expert Recommendations on Cardiac Computed Tomography for Planning Transcatheter Left Atrial Appendage Occlusion. JACC: Cardiovascular Interventions. 2020;13(3):277-292.","DOI":"10.1016\/j.jcin.2019.08.054"},{"issue":"3","key":"806_CR93","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00330-020-07172-2","volume":"31","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Giglio M, Di Marco D, et al. Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT. Eur Radiol. 2021;31(3):1236\u201344.","journal-title":"Eur Radiol"},{"issue":"1","key":"806_CR94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","volume":"4","author":"U Baber","year":"2011","unstructured":"Baber U, Howard VJ, Halperin JL, et al. Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol. 2011;4(1):26\u201332.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"806_CR95","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40291-023-00639-0","volume":"27","author":"G Nakhl\u00e9","year":"2023","unstructured":"Nakhl\u00e9 G, Tardif JC, Roy D, et al. A cost-effectiveness analysis of biomarkers for risk prediction in atrial fibrillation. Mol Diagn Ther. 2023;27(3):383\u201394.","journal-title":"Mol Diagn Ther"},{"issue":"10201","key":"806_CR96","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0140-6736(19)31721-0","volume":"394","author":"ZI Attia","year":"2019","unstructured":"Attia ZI, Noseworthy PA, Lopez-Jimenez F, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet. 2019;394(10201):861\u20137.","journal-title":"Lancet"},{"issue":"2","key":"806_CR97","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1161\/CIRCULATIONAHA.121.057480","volume":"145","author":"S Khurshid","year":"2022","unstructured":"Khurshid S, Friedman S, Reeder C, et al. ECG-based deep learning and clinical risk factors to predict atrial fibrillation. Circulation. 2022;145(2):122\u201333.","journal-title":"Circulation"},{"issue":"3","key":"806_CR98","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/ehjdh\/ztaf019","volume":"6","author":"RM Zimmerman","year":"2025","unstructured":"Zimmerman RM, Hernandez EJ, Tristani-Firouzi M, Yandell M, Steinberg BA. Explainable artificial intelligence for stroke risk stratification in atrial fibrillation. Eur Heart J Digit Health. 2025;6(3):317\u201325.","journal-title":"Eur Heart J Digit Health."},{"issue":"1","key":"806_CR99","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s44325-025-00071-9","volume":"2","author":"AF Pedroso","year":"2025","unstructured":"Pedroso AF, Khera R. Leveraging AI-enhanced digital health with consumer devices for scalable cardiovascular screening, prediction, and monitoring. NPJ Cardiovasc Health. 2025;2(1):34.","journal-title":"NPJ Cardiovasc Health."},{"key":"806_CR100","doi-asserted-by":"publisher","first-page":"1432876","DOI":"10.3389\/fcvm.2024.1432876","volume":"11","author":"Z Papalamprakopoulou","year":"2024","unstructured":"Papalamprakopoulou Z, Stavropoulos D, Moustakidis S, Avgerinos D, Efremidis M, Kampaktsis PN. Artificial intelligence-enabled atrial fibrillation detection using smartwatches: current status and future perspectives. Front Cardiovasc Med. 2024;11:1432876.","journal-title":"Front Cardiovasc Med."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-026-00806-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:03:08Z","timestamp":1787313788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-026-00806-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":100,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1007\/s40256-026-00806-8","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Navid Radfar, Dhir Gala, Harsh Singh, Juan Bello, and Joseph Allencherril declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Navid Radfar - Conceptualization, methodology, project administration, writing (original draft), reviewing and editing. Dhir Gala - Writing (original draft), reviewing and editing. Harsh Singh - Writing (original draft), reviewing and editing. Juan Bello \u2013 Writing (orignal draft), reviewing and editing. Joseph Allencherril - Conceptualization, supervision, reviewing and editing","order":2,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data sharing not applicable to this article as no datasets were generated for this manuscript.","order":3,"name":"Ethics","label":"Data Availability Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}